Proximity proteomics identifies septins and PAK2 as decisive regulators of actomyosin-mediated expulsion of von Willebrand factor
Blood · 2023
DOI: 10.1182/blood.2022017419 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, 2023. Verfasst von Sammy El-Mansi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, Uni…. Hauptthemen laut MEDLINE: von Willebrand Factor, Actomyosin. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wellcome Trust, Medical Research Council, British Heart Foundation.
Abstract (Originalsprache)
In response to tissue injury, within seconds the ultra-large glycoprotein von Willebrand factor (VWF) is released from endothelial storage organelles (Weibel−Palade bodies) into the lumen of the blood vasculature, where it leads to the recruitment of platelets. The marked size of VWF multimers represents an unprecedented burden on the secretory machinery of endothelial cells (ECs). ECs have evolved mechanisms to overcome this, most notably an actomyosin ring that forms, contracts, and squeezes out its unwieldy cargo. Inhibiting the formation or function of these structures represents a novel therapeutic target for thrombotic pathologies, although characterizing proteins associated with such a dynamic process has been challenging. We have combined APEX2 proximity labeling with an innovative dual loss-of-function screen to identify proteins associated with actomyosin ring function. We show that p21 activated kinase 2 (PAK2) recruits septin hetero-oligomers, a molecular interaction that forms a ring around exocytic sites. This cascade of events controls actomyosin ring function, aiding efficient exocytic release. Genetic or pharmacological inhibition of PAK2 or septins led to inefficient release of VWF and a failure to form platelet-catching strings. This new molecular mechanism offers additional therapeutic targets for the control of thrombotic disease and is highly relevant to other secretory systems that employ exocytic actomyosin machinery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
- MRC Laboratory of Molecular Cell Biology, University College London, London, United Kingdom.
- Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
- Cell Signalling & Proteomics Group, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
ORCID-Profile: Sammy El-Mansi, Tom P Mitchell, Vinothini Rajeeve, Pedro Cutillas, Serge Mostowy, Thomas D Nightingale
Förderung
- Wellcome Trust
- Medical Research Council
- British Heart Foundation
Zitieren
APA
El-Mansi, S., Robinson, C. L., Kostelnik, K. B., McCormack, J. J., Mitchell, T. P., Lobato-Márquez, D., Rajeeve, V., Cutillas, P., Cutler, D. F., Mostowy, S., & Nightingale, T. D. (2023). Proximity proteomics identifies septins and PAK2 as decisive regulators of actomyosin-mediated expulsion of von Willebrand factor. Blood. https://doi.org/10.1182/blood.2022017419
Vancouver
El-Mansi S, Robinson CL, Kostelnik KB, McCormack JJ, Mitchell TP, Lobato-Márquez D, et al. Proximity proteomics identifies septins and PAK2 as decisive regulators of actomyosin-mediated expulsion of von Willebrand factor. Blood. 2023. doi:10.1182/blood.2022017419
BibTeX
@article{ElMansi2023,
author = {El-Mansi, Sammy and Robinson, Christopher L and Kostelnik, Katja B and McCormack, Jessica J and Mitchell, Tom P and Lobato-Márquez, Damián and Rajeeve, Vinothini and Cutillas, Pedro and Cutler, Daniel F and Mostowy, Serge and Nightingale, Thomas D},
title = {Proximity proteomics identifies septins and PAK2 as decisive regulators of actomyosin-mediated expulsion of von Willebrand factor},
journal = {Blood},
year = {2023},
doi = {10.1182/blood.2022017419}
}
EUVIMED